Notice of Intent to Publish a Funding Opportunity Announcement for Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)

Key Dates

• April 11, 2022 - Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional). See NOFO PAR-22-136

National Cancer Institute (NCI)

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), the NCI Paul Calabresi Career Development Award for Clinical Oncology (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in cancer research. Special emphasis is placed on training of clinical scientists whose career goals are in clinical cancer research.

The NOFO will allow the appointment of Scholars proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary study to an existing trial; or proposing to gain research experience in a clinical trial led by another investigator as part of their research and career development.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications.

The NOFO is expected to be published in November 2024 with a first expected application due date in February 2025.

This NOFO will utilize the K12 activity code for Clinical Scientist Institutional Career Development Program Awards. Details of the planned NOFO are provided below.
 

The purpose of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research and to promote their career development as cancer researchers.

NCI initiated its K12 program in 1991 to prepare clinical oncologists to be effective scientific partners with basic research scientists. In 1994, the program was renamed the Paul Calabresi Award in Clinical Oncology in honor of the late Dr. Paul Calabresi, a pioneer in the pharmacological treatment of cancer and early translational research.  This NOFO will encourage applications from applicant organizations that propose creative trans-disciplinary and innovative institutional research career development programs in the mission area(s) of the NCI.

NCI K12 programs are required to have at least two oncology specialties represented among the included faculty and the pool of K12 appointees (Scholars). NCI K12 programs are expected to leverage the institution’s unique strengths in these oncology specialties and to incorporate the latest research and technology advancements in designing cutting-edge career development curricula. NCI K12 programs must establish individualized career development plans to accommodate Scholars with different levels of prior research training/experience and assign two mentors, a clinician conducting patient-oriented research and a basic science cancer researcher, to each Scholar.

The award budgets may include salary support for the PD(s)/PI(s) and Scholars, research and development support, and administrative support costs. Scholars are individuals who are appointed to the program and benefit from the proposed activities and experiences involved in the career development program. Scholar costs must be justified as specifically required for the proposed career development program and based on institutional policies for salaries paid to individuals in similar positions, regardless of the source of funds. These expenses must be itemized in the proposed budget. 

Scholar appointments will be up to two (2) years in length, with the option of an extra year for Scholars who would benefit. The application must clearly indicate the number of Scholar appointments proposed for each year. Candidates must have a full-time appointment at the applicant institution or a partnering institution. Scholar support is provided for a minimum of two years and a maximum of three years of consecutive funding for each scholar, consisting of 12-month appointments, provided their progress towards an independent academic career is on track and satisfactory. 

Applicant organizations are encouraged to recruit a pool of potential Scholars and prospective program faculty and mentors from diverse backgrounds, including individuals from underrepresented racial and ethnic groups, persons with disabilities, and women (see NOT-OD-20-031).

 

Funding Information

Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Non-domestic (non-U.S.) Entity (Foreign Organization)
Regional Organization
Eligible Agencies of the Federal Government

Applications are not being solicited at this time. 

Inquiries

Please direct all inquiries to:

Mark Damico, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5630
Email: [email protected]